Solid Carcinoma — Trials

Solid Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

32 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 17
Recruiting: 12
Ph III recruiting: 1
Growth YoY: —
Industry share: 29%
Top sponsor: Memorial Sloan Kettering Cancer Center
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (3)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05054374	A Study of Mirdametinib on Its Own or in Combination With Fulvestrant in People With Solid Tumor Cancer	completed	Phase 1 / Phase 2	6	Memorial Sloan Kettering Cancer CenterOTHER	1	May 23, 2025	clinicaltrials
NCT04200963	A Phase 1a/b Study of IK-175 as a Single Agent and in Combination With Nivolumab in Patients With Locally Advanced or Metastatic Solid Tumors and Urothelial Carcinoma	completed	Phase 1	78	Ikena OncologyINDUSTRY	1	Mar 15, 2024